News

Simreka, simulation software that accelerates materials driven product and manufacturing process innovation using AI, today announced that it has raised a seven figure seed financing round led by High-Tech Gruenderfonds (HTGF) with participation from the SAP.iO Fund. Simreka has built a powerful enterprise simulation software and data service that empowers brands and manufacturers to accelerate their R&D cycles and significantly reduce their time-to-market with products that meet evolving cu

HTGF wins the founders of the former start-up FOND OF as investors for the HTGF III HTGF III was reopened for the entry of the FOND OF founders FOND OF founders participate with 3 million euros HTGF joins FOND OF's new Growth Accelerator xdeck   On the occasion of last year's Family Day, the HTGF announced the second closing of Fund III with a record volume of EUR 316.5 million. This fund has now been reopened to enable the entry of the founders of the successful Cologne

Deep learning and AI have revolutionized how images, sounds and natural language are processed. However, software for Computer-Aided Design (CAD) for the development of technical products is still using traditional techniques. Neural Concept Shape is the first deep learning software solution dedicated to Computer Assisted Engineering and Design. The cloud-based simulation software allows clients to speed up development cycles, enhance product performance and reduce computational costs. Market

As a seed investor, the HTGF invests very early in new technologies, innovations and markets, with the clear goal of bringing market-leading companies along with it. "As Quentic's first institutional investor, we are very excited about the renewed commitment of these two strong partners. It underlines the great potential of the company. The Quentic team has done an outstanding job in the past years and has set the course for the European market leadership in the field of HSE and CSR software", e

Quantum technologies have the potential to propel computer and communication systems to a new level, paving the way for the next major tech revolution. For this to become a reality, however, extremely low operating temperatures verging on absolute zero (–273°C) are required. Industrial-scale implementation had previously been hindered by the absence of a scalable cooling solution – and this is exactly what kiutra is developing. The deep-tech startup is the first company worldwide that is ab

NAVAN Technologies, Inc. (NAVAN), a privately-held biotechnology company enabling the development of next generation cell and gene therapies through its novel, non-viral NanoStraw platform, announced it had closed a seed investment round led by Amgen Ventures, High-Tech Gründerfonds (HTGF), Hemi Ventures, and other institutional and private investors. Based on technology exclusively licensed from Stanford University, NAVAN is also supported by a National Science Foundation STTR Phase II award a

DyNAbind’s Dynamic DNA-Encoded Library technology platform allows hundreds of millions of chemical structures to be simultaneously screened and optimized against a potential drug target protein. This innovation continues to be driven forward with investment from the High-Tech Gründerfonds (HTGF), Technologiegründerfonds Sachsen (TGFS) and existing shareholder TUDAG - TU Dresden AG. Finding a new drug candidate can be like finding a needle in a haystack. Imagine that instead of checking one

High-Tech Gründerfonds (HTGF), BAB Beteiligungs- und Managementgesellschaft Bremen mbH (BBM) and a private investor invest in Bremen start-up miRdetect miRdetect develops an innovative and accurate test method for the detection of testicular cancer Together with BBM and a private investor, High-Tech Gründerfonds (HTGF) is investing a seven-figure sum in the start-up company miRdetect located in Bremen, and founded in 2016. The company founders Meike Spiekermann and Dr. Nina Winter were

ALENTIS Therapeutics (“ALENTIS”), a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer, announced today the completion of a Series A financing of CHF 12.5million (Euro 11.1m; USD 12.5m). The Swiss venture capital firms BioMedPartners and BB Pureos Bioventures co-led the round and were joined by BPI France, Schroder Adveq and the German High-Tech Gründerfonds (HTGF). Markus L.E. Ewert, PhD, MBA has joined the company as Chief Executive Officer. M

High-Tech Gründerfonds has partnered the start-up since the seed round in 2014 Medineering develops robotic assistance systems for use in operating theatres Ulrike Kalapis (HTGF): “Medineering is a real success story. It took the team only a few years to develop a sophisticated, innovative product, and now bring it to market.”   High-Tech Gründerfonds and other investors are selling all of their shares in the robotics start-up Medineering GmbH, based in Munich, to Brai

The use of Artificial Intelligence makes medical findings faster and more reliable: mediaire GmbH is developing innovative methods that help radiologists detect neurodegenerative diseases, such as Alzheimer's or Multiple Sclerosis, earlier and faster. The High-Tech Gründerfonds (HTGF), together with a group of private investors, is investing a large six-digit amount in the growth of this Berlin-based start-up. The goal of mediaire GmbH is to increase patient safety and facilitate everyday